Back to Authors

Park, Boas

A5104195239 | I4210091812

Mayo Clinic

Bristol-Myers Squibb (United States)

Citations 1

Real-World Outcomes with Immuno-Oncology Therapies in Advanced Melanoma: Final Results of the OPTIMIzE Registry Study

Immunotherapy | November 8, 2023 | Volume: 16 | Issue: 1 | Pages: 29-42

10.2217/imt-2022-0292 | PMID 37937397